Bioenergetic Profiling in Glioblastoma Multiforme Patients with Different Clinical Outcomes
Metabolites · 28.02.2023 · 13 (3) · 362
DOI: 10.3390/metabo13030362 ↗Kurz gefasst
Fachartikel in der Zeitschrift Metabolites, online erschienen am 28.02.2023. Verfasst von Vivi Bafiti und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Chemical Biology, National Hellenic Research Foundation, 11635 Athens, Greece. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This research is supported by the European Regional Development Fund of the European Union and Greek national funds through the Operational Program Competitive…, European Regional Development Fund of the European Union.
Abstract (Originalsprache)
The accumulation of cell biomass is associated with dramatically increased bioenergetic and biosynthetic demand. Metabolic reprogramming, once thought as an epiphenomenon, currently relates to disease progression, also in response to extracellular fate-decisive signals. Glioblastoma multiforme patients often suffer misdiagnosis, short survival time, low quality of life, and poor disease management options. Today, tumor genetic testing and histological analysis guide diagnosis and treatment. We and others appreciate that metabolites complement translational biomarkers and molecular signatures in disease profiling and phenotyping. Herein, we coupled a mixed-methods content analysis to a mass spectrometry-based untargeted metabolomic analysis on plasma samples from glioblastoma multiforme patients to delineate the role of metabolic remodeling in biological plasticity and, hence, disease severity. Following data processing and analysis, we established a bioenergetic profile coordinated by the mitochondrial function and redox state, lipids, and energy substrates. Our findings show that epigenetic modulators are key players in glioblastoma multiforme cell metabolism, in particular when microRNAs are considered. We propose that biological plasticity in glioblastoma multiforme is a mechanism of adaptation and resistance to treatment which is eloquently revealed by bioenergetics.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Chemical Biology, National Hellenic Research Foundation, 11635 Athens, Greece.
- Department of Pathology, School of Medicine, University of Patras, 26504 Patras, Greece.
- Department of Neurosurgery, University Hospital of Patras, 26504 Patras, Greece.
- Department of Radiation Oncology, University of Patras Medical School, 26504 Patras, Greece.
ORCID-Profile: Vivi Bafiti, Sotiris Ouzounis, Andreas Theofanopoulos, Dimitrios Kardamakis, Theodora Katsila
Förderung
- This research is supported by the European Regional Development Fund of the European Union and Greek national funds through the Operational Program Competitive…
- European Regional Development Fund of the European Union
Zitieren
APA
Bafiti, V., Ouzounis, S., Siapi, E., Grypari, I. M., Theofanopoulos, A., Panagiotopoulos, V., Zolota, V., Kardamakis, D., & Katsila, T. (2023). Bioenergetic Profiling in Glioblastoma Multiforme Patients with Different Clinical Outcomes. Metabolites, 13(3), 362. https://doi.org/10.3390/metabo13030362
Vancouver
Bafiti V, Ouzounis S, Siapi E, Grypari IM, Theofanopoulos A, Panagiotopoulos V, et al. Bioenergetic Profiling in Glioblastoma Multiforme Patients with Different Clinical Outcomes. Metabolites. 2023;13(3):362. doi:10.3390/metabo13030362
BibTeX
@article{Bafiti2023,
author = {Bafiti, Vivi and Ouzounis, Sotiris and Siapi, Eleni and Grypari, Ioanna Maria and Theofanopoulos, Andreas and Panagiotopoulos, Vasilios and Zolota, Vasiliki and Kardamakis, Dimitrios and Katsila, Theodora},
title = {Bioenergetic Profiling in Glioblastoma Multiforme Patients with Different Clinical Outcomes},
journal = {Metabolites},
year = {2023},
volume = {13},
number = {3},
pages = {362},
doi = {10.3390/metabo13030362}
}
EUVIMED